269 related articles for article (PubMed ID: 16912177)
1. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
[TBL] [Abstract][Full Text] [Related]
2. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
3. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance.
Luo ML; Shen XM; Zhang Y; Wei F; Xu X; Cai Y; Zhang X; Sun YT; Zhan QM; Wu M; Wang MR
Cancer Res; 2006 Dec; 66(24):11690-9. PubMed ID: 17178864
[TBL] [Abstract][Full Text] [Related]
4. Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.
Clark ES; Brown B; Whigham AS; Kochaishvili A; Yarbrough WG; Weaver AM
Oncogene; 2009 Jan; 28(3):431-44. PubMed ID: 18931703
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib.
Timpson P; Wilson AS; Lehrbach GM; Sutherland RL; Musgrove EA; Daly RJ
Cancer Res; 2007 Oct; 67(19):9304-14. PubMed ID: 17909038
[TBL] [Abstract][Full Text] [Related]
6. Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer.
Kelley LC; Shahab S; Weed SA
Clin Exp Metastasis; 2008; 25(4):289-304. PubMed ID: 18324357
[TBL] [Abstract][Full Text] [Related]
7. An update of knowledge on cortactin as a metastatic driver and potential therapeutic target in oral squamous cell carcinoma.
Ramos-García P; González-Moles MÁ; González-Ruiz L; Ayén Á; Ruiz-Ávila I; Navarro-Triviño FJ; Gil-Montoya JA
Oral Dis; 2019 May; 25(4):949-971. PubMed ID: 29878474
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E
Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838
[TBL] [Abstract][Full Text] [Related]
9. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C
J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
[TBL] [Abstract][Full Text] [Related]
12. Cortactin Phosphorylation by Casein Kinase 2 Regulates Actin-Related Protein 2/3 Complex Activity, Invadopodia Function, and Tumor Cell Invasion.
Markwell SM; Ammer AG; Interval ET; Allen JL; Papenberg BW; Hames RA; Castaño JE; Schafer DA; Weed SA
Mol Cancer Res; 2019 Apr; 17(4):987-1001. PubMed ID: 30610108
[TBL] [Abstract][Full Text] [Related]
13. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
[TBL] [Abstract][Full Text] [Related]
14. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines.
Patel AM; Incognito LS; Schechter GL; Wasilenko WJ; Somers KD
Oncogene; 1996 Jan; 12(1):31-5. PubMed ID: 8552396
[TBL] [Abstract][Full Text] [Related]
15. Cortactin is associated with perineural invasion in the deep invasive front area of laryngeal carcinomas.
Ambrosio EP; Rosa FE; Domingues MA; Villacis RA; Coudry Rde A; Tagliarini JV; Soares FA; Kowalski LP; Rogatto SR
Hum Pathol; 2011 Sep; 42(9):1221-9. PubMed ID: 21419472
[TBL] [Abstract][Full Text] [Related]
16. Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.
Dedes KJ; Lopez-Garcia MA; Geyer FC; Lambros MB; Savage K; Vatcheva R; Wilkerson P; Wetterskog D; Lacroix-Triki M; Natrajan R; Reis-Filho JS
Breast Cancer Res Treat; 2010 Dec; 124(3):653-66. PubMed ID: 20213079
[TBL] [Abstract][Full Text] [Related]
17. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma.
Jin C; Jin Y; Gisselsson D; Wennerberg J; Wah TS; Strömbäck B; Kwong YL; Mertens F
Cytogenet Genome Res; 2006; 115(2):99-106. PubMed ID: 17065789
[TBL] [Abstract][Full Text] [Related]
18. Cortactin expression: Association with disease progression and survival in oral squamous cell carcinoma.
Horn D; Gross M; Dyckhoff G; Fuchs J; Grabe N; Weichert W; Herpel E; Herold-Mende C; Lichter P; Hoffmann J; Hess J; Freier K
Head Neck; 2018 Dec; 40(12):2685-2694. PubMed ID: 30456890
[TBL] [Abstract][Full Text] [Related]
19. Combination effects of distinct cores in 11q13 amplification region on cervical lymph node metastasis of oral squamous cell carcinoma.
Sugahara K; Michikawa Y; Ishikawa K; Shoji Y; Iwakawa M; Shibahara T; Imai T
Int J Oncol; 2011 Oct; 39(4):761-9. PubMed ID: 21701773
[TBL] [Abstract][Full Text] [Related]
20. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
Timpson P; Lynch DK; Schramek D; Walker F; Daly RJ
Cancer Res; 2005 Apr; 65(8):3273-80. PubMed ID: 15833860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]